Risk of uncomplicated peptic ulcer in the general population
Study identifier:D5040N00006
ClinicalTrials.gov identifier:NCT01888588
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Risk of uncomplicated peptic ulcer in the general population
Medical condition
Peptic Ulcer [Iowa Type (107680.0010)]
Phase
N/A
Healthy volunteers
No
Study drug
Risk of symptomatic peptic ulcer
Sex
All
Actual Enrollment
25000
Study type
Observational
Age
N/A
Date
Study Start Date: 06 Sept 2012
Primary Completion Date: 06 Sept 2012
Study Completion Date: 06 Sept 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jun 2025 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Cases Patients with symptomatic peptic ulcer (UPU) | Drug: Risk of symptomatic peptic ulcer Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use |
| Control group Control group without symptomatic peptic ulcer (UPU). | Drug: Risk of symptomatic peptic ulcer Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use |
Contacts
Investigators
Principal Investigator
Luis A Garcia Rodriguez
CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )
